Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
The role of herpesvirus entry mediator as a negative regulator of T cell–mediated responses
Yang Wang, … , Klaus Pfeffer, Yang-Xin Fu
Yang Wang, … , Klaus Pfeffer, Yang-Xin Fu
Published March 1, 2005
Citation Information: J Clin Invest. 2005;115(3):711-717. https://doi.org/10.1172/JCI22982.
View: Text | PDF
Article Autoimmunity

The role of herpesvirus entry mediator as a negative regulator of T cell–mediated responses

  • Text
  • PDF
Abstract

Herpesvirus entry mediator (HVEM), a TNF receptor superfamily member, has been previously described as a T cell costimulatory receptor. Surprisingly, HVEM–/– T cells showed enhanced responses to in vitro concanavalin A (ConA) stimulation when compared with WT T cells. Consistent with these findings, HVEM–/– mice exhibited increased morbidity and mortality as compared with WT mice in a model of ConA-mediated T cell–dependent autoimmune hepatitis. HVEM–/– mice produced higher levels of multiple cytokines, which were dependent on the presence of CD4+ T cells. Furthermore, HVEM–/– mice were more susceptible to MOG peptide–induced experimental autoimmune encephalopathy, and they showed increased T cell proliferation and cytokine production in response to antigen-specific challenge. Taken together, our data revealed an unexpected regulatory role of HVEM in T cell–mediated immune responses and autoimmune diseases.

Authors

Yang Wang, Sumit K. Subudhi, Robert A. Anders, James Lo, Yonglian Sun, Sarah Blink, Yugang Wang, Jing Wang, Xiaojuan Liu, Karin Mink, Daniel Degrandi, Klaus Pfeffer, Yang-Xin Fu

×

Figure 2

Options: View larger image (or click on image) Download as PowerPoint
Overreactive HVEM-deficient T cells in vitro. (A) HVEM –/ – T cells are ...
Overreactive HVEM-deficient T cells in vitro. (A) HVEM –/ – T cells are more sensitive to stimulation by suboptimal anti-CD3 mAb as shown by 3H-thymidine incorporation assay. Data represent 3H-thymidine incorporation in cpm ± SD. One of 4 independent experiments is shown. (B) Splenocytes (2 × 105 per well) from WT and HVEM –/ – mice were cultured in 96-well plates with 0, 0.3, 0.6, and 1.2 μg/ml ConA in vitro. HVEM –/ – mice showed significantly increased response to ConA at all concentrations (P < 0.01). Data represent 1 of 6 independent experiments. (C) Cytokine levels in culture supernatants from B were determined by cytokine bead assay. The cells from HVEM –/ – mice also produced significantly higher levels of cytokines (P < 0.001). Representative data are shown from 1 of 3 independent experiments. (D) HVEM deficiency in both T cells and APCs contributes to the higher T cell responses to ConA. T cells from HVEM –/ – mice (T-KO) showed higher proliferation than T cells from WT mice in response to ConA when APCs from WT mice were provided (P < 0.01), and APCs from HVEM –/ – mice (APC-KO) also provided better stimulation than APCs from WT mice (P < 0.01) when T cells from WT mice were used as responders. Representative data are shown from 3 independent experiments. (E) Increased HVEM –/ – T cell response but not LIGHT –/ – T cell response to ConA in vitro. Splenocytes from WT HVEM –/ – and LIGHT –/ – mice were collected and cultured with ConA. The proliferation was determined by 3H-thymidine incorporation assay (P < 0.01), and cytokine levels were determined by cytokine bead assay (P < 0.05).

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts